Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells (Q28548449)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells	scientific article

Statements

instance of

scholarly article

0 references

title

Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells (English)

0 references

author

Barbara Bröker

object named as

Barbara M Bröker

series ordinal

4

0 references

Alexander Dressel

object named as

Alexander Dressel

series ordinal

5

0 references

author name string

Melanie Korsen

series ordinal

1

0 references

Sara Bragado Alonso

series ordinal

2

0 references

Lizzy Peix

series ordinal

3

0 references

language of work or name

English

0 references

publication date

2015

0 references

published in

PLOS One

0 references

volume

10

0 references

issue

6

0 references

page(s)

e0129182

0 references

copyright license

Creative Commons Attribution 4.0 International

start time

18 June 2015

1 reference

stated in

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Therapeutic decisions in multiple sclerosis: moving beyond efficacy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472752

retrieved

19 March 2017

Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472752

retrieved

19 March 2017

Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472752

retrieved

19 March 2017

Novel immunomodulatory approaches for the management of multiple sclerosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472752

retrieved

29 September 2017

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472752

retrieved

29 September 2017

The epidemiology of multiple sclerosis in Europe.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472752

retrieved

29 September 2017

Cladribine in the treatment of hairy-cell leukaemia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472752

retrieved

29 September 2017

Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472752

retrieved

29 September 2017

Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472752

retrieved

29 September 2017

Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472752

retrieved

29 September 2017

2-Chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0129182

retrieved

21 January 2018

MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0129182

retrieved

21 January 2018

Mitoxantrone treatment in multiple sclerosis induces TH2-type cytokines.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0129182

retrieved

21 January 2018

Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0129182

retrieved

21 January 2018

Interleukin-8 and RANTES levels in patients with relapsing-remitting multiple sclerosis (RR-MS) treated with cladribine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0129182

retrieved

21 January 2018

Impact of cladribine on soluble adhesion molecules in multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0129182

retrieved

21 January 2018

Immunopathogenesis of multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0129182

retrieved

21 January 2018

Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0129182

retrieved

21 January 2018

Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: Increased interleukin-4 production and associated eosinophilia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0129182

retrieved

21 January 2018

Cladribine exerts an immunomodulatory effect on human and murine dendritic cells.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472752

retrieved

27 November 2018

On the bioavailability of oral and subcutaneous 2-chloro-2'-deoxyadenosine in humans: alternative routes of administration

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26086440

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26086440

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/26086440

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1371/JOURNAL.PONE.0129182

0 references

ADS bibcode

2015PLoSO..1029182K

0 references

PMC publication ID

4472752

0 references

PubMed publication ID

26086440

0 references

ResearchGate publication ID

278790703

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28548449&oldid=1856457523"